Rosuvastatin reduces intima-media thickness in hypercholesterolemic subjects with asymptomatic carotid artery disease: the Asymptomatic Carotid Atherosclerotic Disease in Manfredonia (ACADIM) Study

Bibliography

• Libby P, Aikawa M, Schonbeck U. Cholesterol and atherosclerosis. Biochim Biophys Acta 2000;1529:299-309
   PubMed Web of Science ®Google Scholar
• Deveraj S, Jialal I. Oxidized low-density lipoprotein and atherosclerosis. Int J Clin Lab Res 1996;26:178-84
   PubMedGoogle Scholar
• Riccioni G, De Santis A, Cerasa V, et al. Atherosclerotic plaque formation and risk factors. Int J Immunopathol Pharmacol 2003;16:25-31
   PubMed Web of Science ®Google Scholar
• Lusis AJ. Atherosclerosis. Nature 2000;407:233-41
   PubMed Web of Science ®Google Scholar
• Holvoet P, Mertens A, Verhamme P, et al. Circulating oxidized LDL is a useful marker for typing patients with coronary artery disease. Arterioscler Thromb Vasc Biol 2001;21:844-8
   PubMed Web of Science ®Google Scholar
• Zureik M, Ducimetiere P, Touboul PJ, et al. Common carotid intima-media thickness predicts occurrence of carotid atherosclerotic plaques: longitudinal results from the Aging Vascular Study (EVA) study. Arterioscler Thromb Vasc Biol 2000;20:1622-9
   PubMed Web of Science ®Google Scholar
• Heiss G, Sharrett AR, Barnes R, et al. Carotid atherosclerosis measured by B-mode ultrasound in populations: associations with cardiovascular risk factors in the ARIC Study. Am J Epidemiol 1991;134:250-6
   PubMed Web of Science ®Google Scholar
• Salonen R, Salonen JT. Determinants of carotid intima-media thickness: a population-based ultrasonography study in eastern Finnish men. J Intern Med 1991;229:225-31
   PubMed Web of Science ®Google Scholar
• Davis PH, Dawson JD, Riley WA, Lauer RM. Carotid intimal-medial thickness is related to cardiovascular risk factors measured from childhood through middle age: the Muscatine study. Circulation 2001;104:2815-9
   PubMed Web of Science ®Google Scholar
• Salonen JT, Salonen R. Ultrasonographically assessed carotid morphology and the risk of coronary heart disease. Arterioscler Thromb 1991;11:1245-9
   PubMed Web of Science ®Google Scholar
• Wilt TJ, Bloomfield HE, MacDonald R, et al. Effectiveness of statin therapy in adults with coronary heart disease. Arch Intern Med 2004;164:1427-36
   PubMed Web of Science ®Google Scholar
• Thavendiranathan P, Bagai A, Brookhart MA, Choudhry NK. Primary prevention of cardiovascular diseases with statin therapy: a meta-analysis of randomized controlled trials. Arch Intern Med 2006;166:2307-13
   PubMed Web of Science ®Google Scholar
• Nissen SE, Nicholls SJ, Sipahi I, et al. Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial. JAMA 2006;295:1556-65
   PubMed Web of Science ®Google Scholar
• Crouse JR, Raichlen JS, Riley WA, et al. Effect of rosuvastatin on progression of carotid intima-media thickness in low-risk individuals with subclinical atherosclerosis: the METEOR Trial. JAMA 2007;297:1344-53
   PubMed Web of Science ®Google Scholar
• National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002;106:3143-421
   PubMed Web of Science ®Google Scholar
• MRC European Carotid Surgery Trial: interim results for symptomatic patients with severe (70–99%) or with mild (0–29%) carotid stenosis. European Carotid Surgery Trialists' Collaborative Group. Lancet 1991;337:1235-43
   PubMed Web of Science ®Google Scholar
• Kanters SD, Algra A, van Leeuwen MS, Banga JD. Reproducibility of in vivo carotid intima-media thickness measurements. Stroke 1997;28:665-71
   PubMed Web of Science ®Google Scholar
• Howard G, Sharrett AR, Heiss G, et al. Carotid artery intimal-medial thickness distribution in general populations as evaluated by B-mode ultrasound. Stroke 1993;24:1297-304
   PubMed Web of Science ®Google Scholar
• Crouse JR, Byngton RP, Bond MG. Pravastatin, lipids and atherosclerosis in the carotid arteries (PLAC II). Am J Cardiol 1995;75:455-9
   PubMed Web of Science ®Google Scholar
• Taylor AJ, Kent SM, Flaherty PJ, et al. ARBITER: arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol: a randomized trial comparing the effects of atorvastatin and pravastatin on carotid intima medial thickness. Circulation 2002;106:2055-60
   PubMed Web of Science ®Google Scholar
• Salonen R, Nyyssonen K, Porkkala E, et al. Kuopio Atherosclerosis Prevention Study (KAPS). A population-based primary preventive trial of the effect of LDL lowering on atherosclerotic progression in carotid and femoral arteries. Circulation 1995;92:1758-64
   PubMed Web of Science ®Google Scholar
• Igarashi M, Takeda Y, Mori S, et al. BAYw6228 suppresses accumulation of macrophages in balloon-induced intimal thickening of rabbit carotid artery. Atherosclerosis 1997;128:251-4
   PubMedGoogle Scholar
• Igarashi M, Takeda Y, Mori S, et al. Suppression of neointimal thickening by a newly developed HMG-CoA reductase inhibitor, BAYw6228, and its inhibitory effect on vascular smooth muscle cell growth. Br J Pharmacol 1997;120:1172-8
   PubMed Web of Science ®Google Scholar
• Pauletto O, Puato M, Faggin E, Sartore S. Low-dose cerivastatin inhibits spontaneous atherogenesis in heterozygous Watanabe hyper lipidemic rabbits. J Vasc Res 2000;37:189-94
   PubMedGoogle Scholar
• Youssef F, Seifalian AM, Jagroop IA, et al. The early effect of lipid-lowering treatment on carotid and femoral intima media thickness (IMT). Eur J Vasc Endovasc Surg 2002;23:358-64
   PubMed Web of Science ®Google Scholar
• Jones PH, Davidson MH, Stein EA, et al. Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR Trial). Am J Cardiol 2003;92:152-60
   PubMed Web of Science ®Google Scholar
• Schuster H, Barter PJ, Stender S, et al.; Effective Reductions in Cholesterol Using Rosuvastatin Therapy I Study Group. Effects of switching statins on achievement of lipid goals: measuring Effective Reductions in Cholesterol Using Rosuvastatin Therapy (MERCURY I) study. Am Heart J 2004;147:705-12
   PubMed Web of Science ®Google Scholar
• Leiter L, Rosenson RS, Stein E, et al. Efficacy and safety of rosuvastatin 40 mg versus atorvastatin 80 mg in high-risk patients with hypercholesterolemia: results of the POLARIS study. Atherosclerosis 2007;194:154-64
   PubMed Web of Science ®Google Scholar
• Davis M, Atwal AS, Nair DR, et al. The effect of short-term lipid lowering with atorvastatin on carotid artery intima media thickness in patients with peripheral vascular disease: a pilot study. Curr Med Res Opin 2000;16:198-204
   PubMed Web of Science ®Google Scholar
• Ridker PM, Fonseca FA, Genest J, et al. Baseline characteristics of participants in the JUPITER trial, a randomized placebo-controlled primary prevention trial of statin therapy among individuals with low low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein. Am J Cardiol 2007;100:1659-64
   PubMed Web of Science ®Google Scholar
• Ridker PM; JUPITER Study Group. Rosuvastatin in the primary prevention of cardiovascular disease among patients with low levels of low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein: rationale and design of the JUPITER trial. Circulation 2003;108:2292-7
   PubMed Web of Science ®Google Scholar